Skip to main content
. 2014 Jun 3;7(4):413–426. doi: 10.1007/s40271-014-0064-1

Table 3.

Willingness to pay for chronic obstructive pulmonary disease attributes (N = 515)

Attributes and levels Marginal effect (95 % CI) Marginal WTP to avoid level (95 % CI)
Relieves symptoms (reference: complete relief)
 Little or no relief −1.23 (−1.33, −1.12) $63.62 (58.16–69.08)
 Some relief −0.54 (−0.64, −0.43) $27.74 (22.28–33.20)
Feel medicine start to work (reference: within 5 min)
 Within 20 min −0.19 (−0.24, −0.15) $10.00 (7.74–12.27)
 Within 30 min or more −0.25 (−0.30, −0.21) $13.02 (10.75–15.28)
Ease of use (reference: quick and easy)
 Requires some practice and care −0.09 (−0.14, −0.04) $4.75 (2.25–7.25)
 More difficult and time-consuming −0.30 (−0.35, −0.25) $15.53 (13.03–18.03)
Rescue medicine use (reference: rarely, 1–2 times per week or less)
 3–5 times per week −0.38 (−0.48, −0.29) $19.83 (14.99–24.67)
 Every day −0.61 (−0.70, −0.52) $31.57 (26.73–36.41)
Side effects (reference: no side effects)
 Mild side effects −0.29 (−0.33, −0.24) $14.81 (12.40–17.22)
 Moderate to severe side effects −1.13 (−1.18, −1.09) $58.69 (56.28–61.11)

Reference was the most favorable level for each COPD medication attribute. 95 % CIs that did not include zero were considered to be statistically significant

CI confidence interval, COPD chronic obstructive pulmonary disease, WTP willingness to pay